FDA Safety Measures May not Reduce Death from Pain Killers
Adam M. Kaye: 0000-0002-7224-3322
The U.S. Food and Drug Administration today approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA) prescription pain killers (opioids), highly potent drugs approved for moderate to severe, persistent pain that requires treatment for an extended period.
Kaye, A. M.
FDA Safety Measures May not Reduce Death from Pain Killers.
RxEconsult, LLC, ,